MGAT2 |
Last Update:2016-03-11 |
β1,4-N-Acetylglucosaminyltransferase-II (MGAT2) transfers GlcNAc to β1-2 of Manα1-6(GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ1-Asn, which is generated by mannosidase taking two mannoses from Manα1-6(Manα1-3)Manα1-6(GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ1-Asn synthesized by MGAT1, and synthesizes the GlcNAcb1-2Mana1-6(GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4GlcNAcb1-Asn structure. Mgat2-deficient mice show reduction of N-linked glycans including N-acetyllactosamine and result in lethality after birth.
|
||
JCGG-STR009312
GlyTouCan:
G61751GZ
GlyCosmos Glycans:
G61751GZ
|
JCGG-STR009224
GlyTouCan:
G39213VZ
GlyCosmos Glycans:
G39213VZ
|
MGAT2 Alias | |
Designation | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
Organism | Homo sapiens |
GeneID | 4247 |
HGNC | MGAT2 (7045) |
mRNA | NM_002408 |
map | 14q21 |
Protein | NP_002399 |
EC# | 2.4.1.143 |
CAZy | GT16 |
GlyCosmos Glycogenes | MGAT2 |
OMIM | 602616 |
CDG IIa , Congenital Disorder of Glycosylation type IIa | |
GDGDB | CON00358 |
Human Protein Atlas | ENSG00000168282 |
data available from v22.proteinatlas.org